Immupharma Plclse Aimimmis A Specialty Biopharmaceutical Company That Discovers And Develops Peptide Based Therapeuticsthe Company S Portfolio Includes Novel Peptide Therapeutics For Autoimmune Diseases And Anti Infectivesthe Lead Programp140 Is A First In Classimmune Tolerance Restorerfor The Treatment Of Slesystemic Lupus Erythematosusand Cidpchronic Idiopathic Demyelinating Polyneuropathyand Preclinical Models Suggest Therapeutic Activity For Many Other Autoimmune Diseases That Share The Same Mechanism Of Action
